{"url_path":"/sec/worx/8-k/2026-06-23/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-23","source_url":"https://www.sec.gov/Archives/edgar/data/1674227/0001213900-26-071062-index.html","accession_number":"0001213900-26-071062","cik":"0001674227","ticker":"WORX","issuer_name":"SCWorx Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674227/0001213900-26-071062-index.html","primary_entity_key":"0001674227","primary_entity_name":"SCWorx Corp."},"word_count":493,"has_tables":true,"body_markdown":"Item 8.01. Other Events.\n\n \n\nOn\nJune 17, 2026, SCWorx Corp. (the “Company”) received a written decision (the “Decision”) from a Hearings Panel (the\n“Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) granting the Company’s request to continue the listing of its common\nstock on Nasdaq, subject to the conditions described below.\n\n \n\nAs\npreviously disclosed, trading in the Company’s common stock was suspended on April 14, 2026 as a result of the Company’s failure to satisfy\nthe minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2), which requires that the Company maintain a minimum closing bid price\nof $1.00 per share (the “Bid Price Rule”). The Company appealed the Staff’s delisting determination to the Panel, and the Decision\nresolves that appeal.\n\n \n\nUnder\nthe terms of the Decision, the Company must satisfy the following conditions in order for trading of its common stock to be reinstated\non Nasdaq: (i) on or before July 22, 2026, the Company must obtain shareholder approval for a reverse stock split at a ratio sufficient\nto achieve a post-split price reasonably expected to sustain compliance with the Bid Price Rule; (ii) on or before August 3, 2026, the\nCompany must effect a reverse stock split; and (iii) on or before August 28, 2026, the Company must demonstrate compliance with the Bid\nPrice Rule by evidencing a closing bid price at or above $1.00 per share for a minimum of 20 consecutive trading days.\n\n \n\nIf\nthe Company does not satisfy these conditions by the applicable deadlines, its common stock would be delisted from Nasdaq and trading\non Nasdaq would not be reinstated, in which case the common stock would continue to be quoted on the OTC Markets, subject to compliance\nwith applicable OTC Markets rules. The Panel reserved the right to reconsider the terms of the exception it granted, should any developments\narise that, in the Panel’s judgment, make continued listing of the Company’s securities inadvisable or unwarranted. In addition, under\napplicable Nasdaq rules, the Nasdaq Listing and Hearing Review Council may, on its own motion, determine to review the Decision within\n45 calendar days after its issuance, and upon any such review may affirm, modify, reverse, dismiss or remand the Decision.\n\n \n\nIn\nconnection with the suspension of trading on Nasdaq, the Company has received approval from OTC Markets to have its common stock quoted\non the OTCQB Market.\n\n \n\nOn\nJune 23, 2026, the Company issued a press release announcing the Decision. A copy of the press release is furnished as Exhibit 99.1 to\nthis Current Report on Form 8-K. The information in Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the\nSecurities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and\nshall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except\nas expressly set forth by specific reference in such a filing."}